A PIL has been filed before the Supreme Court by two homoeopathic physicians, seeking direction upon the Central Government to permit homoeopathic treatment of mild cases of COVID-19.
The Petitioners, Dr. Ravi M. Nair and Dr. Asok Kumar Das, have sought that the Ministry of AYUSH be directed to approve treatment of mild cases by homoeopathic medicines stand alone, and of severe to critical cases by adopting integrated approach of giving allopathic medicines with add-on therapy.
They have claimed, based on their "observational research" that there are a certain homeopathic medicines that could help in preventing and combating the virus and even though they have been successful in coming up with such a solution, the state boards and authorities are holding up approvals for the clinical trials.
"This act of arbitrarily holding up approval and stagnating the process at such a crucial time when millions of lives could be saved owing to these medications, violates the right guaranteed under Article 21 of the Constitution," they have stated.
The Petitioners, through Advocate Suvidutt MS, claim that homoeopathic system of medicine has "ample scope" to treat COVID-19 successfully, as it is not based on the causative pathogenic microbes. Further, homoeopathic treatment may have the following advantages:
It is submitted that whereas confirmed diagnosis of COVID-19 can be done only by employing the costly RT-PCR test of nasopharyngeal swab, under homoeopathic treatment there is lesser need for costly laboratory investigations.
Other claims made by the Petitioners include: